213 related articles for article (PubMed ID: 21830023)
1. Rituximab in steroid refractory autoimmune hemolytic anemia.
Gupta N; Sharma S; Seth T; Mishra P; Mahapatra M; Kumar S; Kapoor R; Agarwal N
Indian J Pediatr; 2012 Jun; 79(6):803-5. PubMed ID: 21830023
[TBL] [Abstract][Full Text] [Related]
2. Brucellosis-induced autoimmune hemolytic anemia treated with rituximab.
Bourantas LK; Pappas G; Kapsali E; Gougopoulou D; Papamichail D; Bourantas KL
Ann Pharmacother; 2010 Oct; 44(10):1677-80. PubMed ID: 20823278
[TBL] [Abstract][Full Text] [Related]
3. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.
So MW; Koo BS; Kim YJ; Kim YG; Lee CK; Yoo B
Mod Rheumatol; 2014 Sep; 24(5):855-7. PubMed ID: 24517558
[TBL] [Abstract][Full Text] [Related]
4. Anti B cell targeted therapy for autoimmune hemolytic anemia in an infant.
Makadia D; Siddaiahgari SR; Latha MS
Indian J Pharmacol; 2013; 45(5):526-7. PubMed ID: 24130393
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment with rituximab of an infant with refractory autoimmune hemolytic anemia.
Moriya K; Matsuhashi T; Onuma M; Niizuma H; Rikiishi T; Asada H; Suzuki J; Sasahara Y; Kure S
Int J Hematol; 2013 Aug; 98(2):237-9. PubMed ID: 23702915
[TBL] [Abstract][Full Text] [Related]
6. [Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].
Ono K; Sato T; Iyama S; Tatekoshi A; Hashimoto A; Kamihara Y; Horiguchi H; Kikuchi S; Takada K; Hayashi T; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kato J
Rinsho Ketsueki; 2013 Nov; 54(11):2053-5. PubMed ID: 24305538
[TBL] [Abstract][Full Text] [Related]
7. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
[TBL] [Abstract][Full Text] [Related]
8. The role of rituximab in adults with warm antibody autoimmune hemolytic anemia.
Dierickx D; Kentos A; Delannoy A
Blood; 2015 May; 125(21):3223-9. PubMed ID: 25827833
[TBL] [Abstract][Full Text] [Related]
9. Severe refractory autoimmune hemolytic anemia with five-year complete hematologic response to third course of treatment with rituximab: a case report.
Abadie K; Hege KM
J Med Case Rep; 2014 Jun; 8():175. PubMed ID: 24889270
[TBL] [Abstract][Full Text] [Related]
10. Primary IgA-mediated Autoimmune Hemolytic Anemia in an Infant Successfully Treated With Rituximab.
van den Akker M; Smolders D; Mahieu S; Bonouvrie K; van der Werf Ten Bosch J
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e615-e619. PubMed ID: 32118812
[TBL] [Abstract][Full Text] [Related]
11. Case Report: Tuberculosis-Induced Autoimmune Hemolytic Anemia.
Alebbi SM; Kambal A; Abo Samra H; Sharaf Eldean MZ; Mohamed SF; Al-Shokri SD
Am J Trop Med Hyg; 2023 Feb; 108(2):313-316. PubMed ID: 36535253
[TBL] [Abstract][Full Text] [Related]
12. Rituximab for treatment of autoimmune hemolytic anemia.
Kuzmanovic M; Jurisic V
Indian Pediatr; 2012 Aug; 49(8):672-4. PubMed ID: 22962244
[TBL] [Abstract][Full Text] [Related]
13. Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia.
Heidel F; Lipka DB; von Auer C; Huber C; Scharrer I; Hess G
Thromb Haemost; 2007 Feb; 97(2):228-33. PubMed ID: 17264951
[TBL] [Abstract][Full Text] [Related]
14. Warm autoimmune hemolytic anemia: advances in pathophysiology and treatment.
Michel M
Presse Med; 2014 Apr; 43(4 Pt 2):e97-e104. PubMed ID: 24680421
[TBL] [Abstract][Full Text] [Related]
15. Adult Evans syndrome: complete hematologic recovery with steroids and rituximab: a case report.
Santiago-Ríos KJ; Reyes O; Cruz A; Rodríguez-Pabón N; Cáceres W
Bol Asoc Med P R; 2010; 102(2):33-6. PubMed ID: 20939201
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Rituximab in Refractory Cold Agglutinin Hemolytic Anemia in a Patient with Ataxia-Telangiectasia.
Abdulhag UN; Liebster D; Eisenstein EM; Berkun Y
Isr Med Assoc J; 2015 Jul; 17(7):455-6. PubMed ID: 26357726
[No Abstract] [Full Text] [Related]
17. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
Gupta N; Kavuru S; Patel D; Janson D; Driscoll N; Ahmed S; Rai KR
Leukemia; 2002 Oct; 16(10):2092-5. PubMed ID: 12357362
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post-hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation.
O'Connell N; Goodyer M; Gleeson M; Storey L; Williams M; Cotter M; O'Marcaigh A; Smith O
Pediatr Transplant; 2014 Feb; 18(1):E22-4. PubMed ID: 24168326
[TBL] [Abstract][Full Text] [Related]
19. Livedo reticularis associated with autoimmune hemolytic anemia: prolonged remission induced by peripheral blood stem cell transplantation relapse after 10 years and restoration of hemoglobin levels by rituximab.
Ferreira E; Feitosa A; Hamerschlak N; Scheinberg MA
Rev Bras Reumatol; 2012; 52(1):122-4. PubMed ID: 22286652
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies.
Reynaud Q; Durieu I; Dutertre M; Ledochowski S; Durupt S; Michallet AS; Vital-Durand D; Lega JC
Autoimmun Rev; 2015 Apr; 14(4):304-13. PubMed ID: 25497766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]